Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00610207 · ClinicalTrials.gov registry record · NA

Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft

A NA study, sponsored by Cook Group Incorporated.

Terminated
Registry status
NA
Development phase
21
Enrollment target

NCT00610207: Clinical Trial NA study, sponsored by Cook Group Incorporated.

NCT00610207 is a NA study that was terminated before completion, run by Cook Group Incorporated. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00610207, a NA study, was terminated before completion, sponsored by Cook Group Incorporated.

TERMINATED
Registry status
NA
Development phase
21 participants
Enrollment target

Study Summary

Healing anal fistulas in Crohn's patients with an anal fistula plug.

Primary Outcome

Fistula closure is defined as absence of drainage at the external fistula opening.

Interventions

  • DEVICE Surgisis Biodesign Anal Fistula Plug (SurgiSIS AFP)

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2007-03
Est. Completion 2010-04
Phase NA
Cook Group Incorporated

31 total trials

Why NCT00610207 stopped before completion

NCT00610207 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Surgisis Biodesign Anal Fistula Plug (SurgiSIS AFP) is the first listed.

NCT00610207 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00610207 about?

NCT00610207 is a clinical study titled "Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa Graft". Healing anal fistulas in Crohn's patients with an anal fistula plug.

What is the current status of trial NCT00610207?

This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2007-03. Estimated completion is 2010-04.

What interventions are being tested in trial NCT00610207?

The interventions under investigation include: Surgisis Biodesign Anal Fistula Plug (SurgiSIS AFP) (DEVICE).

Who is sponsoring clinical trial NCT00610207?

This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00610207's enrollment target sits among peer trials

21 1762nd of 2000 higher than 233 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02447874 · 21 participants · Phase 1

    Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

  • NCT03826992 · 21 participants · Phase 1

    Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia

  • NCT04107077 · 21 participants · Phase 2

    Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

  • NCT04158635 · 21 participants · Phase 1

    Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00610207, the US trial registry maintained by the National Library of Medicine. NCT00610207 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.